Notice Pursuant to the National Cooperative Research and Production Act of 1993-Center for Medical Interoperability, Inc., 78908 [2014-30672]

Download as PDF 78908 Federal Register / Vol. 79, No. 250 / Wednesday, December 31, 2014 / Notices DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Antitrust Division Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Vehicle to Infrastructure (V2I) Consortium Notice Pursuant to the National Cooperative Research and Production Act of 1993—Pistoia Alliance, Inc. mstockstill on DSK4VPTVN1PROD with NOTICES Notice is hereby given that, on December 3, 2014, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Vehicle to Infrastructure (V2I) Consortium (‘‘V2I Consortium’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to section 6(b) of the Act, the identities of the parties to the venture are: Chrysler Group LLC, Auburn Hills, MI; Ford Motor Company—Research and Innovation Center, Dearborn, MI; General Motors Company—Research and Development Center, Warren, MI; Honda R&D Americas, Inc., Southfield, MI; Hyundai-Kia America Technical Center, Inc., Superior Township, MI; Mazda Motor of America, Inc., Irvine, CA; Mercedes-Benz Research & Development North America, Inc., Sunnyvale, CA; Nissan Technical Center North America Inc., Farmington Hills, MI; Fuji Heavy Industries USA, Inc., Subaru, Cherry Hill, NJ; Volkswagen/ Audi of America, Auburn Hills, MI; and Volvo Group North America, Costa Mesa, CA. The general area of V2I Consortium’s planned activity is to engage in a collaborative effort in order to gain further knowledge and understanding of connected vehicle interactions and/or applications for vehicles that are intended to transform surface transportation safety, mobility, and environmental performance through a connected vehicle environment. Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2014–30673 Filed 12–30–14; 8:45 am] Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2014–30670 Filed 12–30–14; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Center for Medical Interoperability, Inc. Notice is hereby given that, on November 12, 2014, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, BILLING CODE P VerDate Sep<11>2014 Notice is hereby given that, on November 20, 2014, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Pistoia Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Hewlett-Packard Company, Palo Alto, CA; Etzard Stotle (individual member), Arlesheim, SWITZERLAND; Patcore Inc., Shinagawa-ku, Tokyo, JAPAN; and University of Reading, Reading, Berkshire, UNITED KINGDOM, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Pistoia Alliance, Inc. intends to file additional written notifications disclosing all changes in membership. On May 28, 2009, Pistoia Alliance, Inc. filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on July 15, 2009 (74 FR 34364). The last notification was filed with the Department on September 5, 2014. A notice was published in the Federal Register pursuant to section 6(b) of the Act on October 9, 2014 (79 FR 61098). 22:02 Dec 30, 2014 Jkt 235001 PO 00000 Frm 00130 Fmt 4703 Sfmt 4703 15 U.S.C. 4301 et seq. (‘‘the Act’’), Center For Medical Interoperability, Inc. (‘‘The Center’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the name and principal place of business of the standards development organization and (2) the nature and scope of its standards development activities. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to section 6(b) of the Act, the name and principal place of business of the standards development organization is: Center for Medical Interoperability, Inc., La Jolla, CA. The nature and scope of The Center’s standards development activities are: Promoting healthcare and enhancing the quality of or access to healthcare by the public through the advancement of interoperability of medical devices and information systems. Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2014–30672 Filed 12–30–14; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—ASTM International Standards Notice is hereby given that, on December 9, 2014, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), the American Society of ASTM International (‘‘ASTM’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing additions or changes to its standards development activities. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, ASTM has provided an updated list of current, ongoing ASTM standards activities originating between September 2014 and December 2014 designated as Work Items. A complete listing of ASTM Work Items along with a brief description of each, is available at http://www.astm.org. E:\FR\FM\31DEN1.SGM 31DEN1

Agencies

[Federal Register Volume 79, Number 250 (Wednesday, December 31, 2014)]
[Notices]
[Page 78908]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-30672]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Center for Medical Interoperability, Inc.

    Notice is hereby given that, on November 12, 2014, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Center For Medical 
Interoperability, Inc. (``The Center'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing (1) the name and principal place of business of 
the standards development organization and (2) the nature and scope of 
its standards development activities. The notifications were filed for 
the purpose of invoking the Act's provisions limiting the recovery of 
antitrust plaintiffs to actual damages under specified circumstances.
    Pursuant to section 6(b) of the Act, the name and principal place 
of business of the standards development organization is: Center for 
Medical Interoperability, Inc., La Jolla, CA. The nature and scope of 
The Center's standards development activities are: Promoting healthcare 
and enhancing the quality of or access to healthcare by the public 
through the advancement of interoperability of medical devices and 
information systems.

Patricia A. Brink,
 Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2014-30672 Filed 12-30-14; 8:45 am]
BILLING CODE P